FibroGen, Inc.
USD9.07
-0.15 (-1.63%)
CEO
Thane Wettig
IPO Date
2014-11-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.10
Prev. Close
$9.22
Day Low
$9.02
Day High
$9.21
52W Low
$4.85
52W High
$21.95
Market Cap
$0.04B
Volume
0.03M
| -27.8 |
| 31 Dec 2023 | FY | 91.5% | -607.3% | 139.2% | -67.1% | -0.83 | 1.52 | -7.6 |
| 31 Dec 2022 | FY | 85.6% | -208.7% | 1369.2% | -48.1% | -4.19 | 1.80 | -127.6 |
| 31 Dec 2021 | FY | -90.9% | -123.3% | -138.7% | -37.5% | 0.48 | 2.10 | -112.2 |
| 31 Dec 2020 | FY | 95.0% | -107.4% | -44.8% | -22.9% | 0.09 | 4.63 | -440.2 |
| 31 Dec 2019 | FY | 99.6% | -30.0% | -14.9% | -9.0% | 0.10 | 6.84 | -1206.9 |
| 31 Dec 2018 | FY | -10.7% | -40.6% | -17.0% | -9.8% | 0.19 | 7.75 | -1125.4 |
| 31 Dec 2017 | FY | -56.4% | -100.4% | -22.4% | -14.0% | 0.17 | 9.69 | -685.3 |
| 31 Dec 2016 | FY | -4.2% | -34.3% | -39.6% | -13.1% | 0.62 | 4.09 | -544.2 |
| 0.2 |
| 30 Sept 2025 | Q3 | 87.5% | 13798.6% | -871.9% | 108.4% | -1.24 | 3.71 | 0.1 |
| 30 Jun 2025 | Q2 | 77.3% | -564.0% | 3.4% | -4.3% | -0.33 | 1.04 | -0.7 |
| 31 Mar 2025 | Q1 | 78.9% | 169.4% | -2.1% | 2.8% | -0.34 | 2.02 | 42.2 |
| 31 Dec 2024 | Q4 | 83.2% | -14.6% | -8.0% | 8.4% | -0.40 | 1.47 | 0.7 |
| 30 Sept 2024 | Q3 | 88.6% | -36.9% | 7.0% | -6.5% | -0.33 | 1.28 | -0.6 |
| 30 Jun 2024 | Q2 | -3156.5% | -1557.5% | 6.7% | -5.3% | -0.63 | 1.41 | -1.2 |
| 31 Mar 2024 | Q1 | -128.0% | -129.8% | 14.4% | -9.0% | -0.81 | 1.41 | -44.3 |
| 31 Dec 2023 | Q4 | 80.1% | -207.2% | 27.5% | -13.3% | -0.83 | 1.52 | -9.7 |